Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic ArthritisJurgen Sota, Luca Cantarini, Antonella Insalaco et al.|Frontiers in Pharmacology|2019Cited by 616
Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki diseaseChiea Chuen Khor, Martin L. Hibberd, Sonia Dávila et al.|Nature Genetics|2011Cited by 355
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseasesAdriana A. de Jesus, Vibke Lilleby, Yangfeng Hou et al.|Journal of Clinical Investigation|2019Cited by 238
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort studyAlessandro Consolaro, Rita Consolini, Gabriella Giancane et al.|The Lancet Child & Adolescent Health|2019Cited by 214
The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: A retrospective cases seriesIsabelle Koné‐Paut, Maryam Piram, Rolando Cimaz et al.|Autoimmunity Reviews|2018Cited by 129